Your browser doesn't support javascript.
loading
Treatment pathways and clinical outcomes in Hodgkin lymphoma outside Europe and North America: results from the international, multicenter, retrospective, B-HOLISTIC study.
Ferhanoglu, Burhan; Kim, Tae Min; Karduss, Amado; Brittain, David; Tumyan, Gayane; Al-Mansour, Mubarak; Zerga, Marta; Song, Yuqin; Rivas-Vera, Silvia; Kwong, Yok Lam; Lim, Soon Thye; Yeh, Su-Peng; Abdillah, Arif; Huang, Zhongwen; Dalal, Mehul; Wan, Hui; Hertzberg, Mark.
Affiliation
  • Ferhanoglu B; Division of Hematology, Department of Internal Medicine, Koç University School of Medicine, Istanbul, Turkey.
  • Kim TM; Department of Internal Medicine, Seoul National University Hospital, Seoul National University Cancer Research Institute, Seoul, South Korea.
  • Karduss A; Bone Marrow Transplant Program, Instituto de Cancerologia, Clínica las Américas, Medellín, Colombia.
  • Brittain D; Albert Alberts Stem Cell Transplant Center, Pretoria East Hospital, Pretoria, South Africa.
  • Tumyan G; Department of Chemotherapy of Hemoblastosis, Blokhin Russian Cancer Research Center, Moscow, Russia.
  • Al-Mansour M; Adult Medical Oncology, Princess Noorah Oncology Center, King Abdulaziz Medical City, Ministry of National Guard Health Affairs-Western Region, Jeddah, The Kingdom of Saudi Arabia.
  • Zerga M; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, The Kingdom of Saudi Arabia.
  • Song Y; Department of Hematology, Angel Roffo Institute, Buenos Aires, Argentina.
  • Rivas-Vera S; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital, Beijing, China.
  • Kwong YL; Department of Hematology, Instituto Nacional de Cancerologia Mexico, Mexico City, Mexico.
  • Lim ST; Bone Marrow Transplant Unit, Queen Mary Hospital, Hong Kong, China.
  • Yeh SP; Hematology Division, Medical Oncology and Bone Marrow Transplantation, Department of Medicine, University of Hong Kong, Hong Kong, China.
  • Abdillah A; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Huang Z; Division of Hematology and Oncology, Department of Medicine, China Medical University Hospital, Taichung, Taiwan.
  • Dalal M; Takeda Pharmaceuticals International AG-Singapore Branch, Singapore, Singapore.
  • Wan H; Takeda R&D Data Sciences Institute, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA.
  • Hertzberg M; Takeda R&D Data Sciences Institute, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA.
Leuk Lymphoma ; 63(14): 3317-3330, 2022 Dec.
Article in En | MEDLINE | ID: mdl-36200380
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / Hematopoietic Stem Cell Transplantation Type of study: Clinical_trials / Observational_studies Limits: Adult / Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Turquía Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / Hematopoietic Stem Cell Transplantation Type of study: Clinical_trials / Observational_studies Limits: Adult / Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Turquía Country of publication: Estados Unidos